Base Molecular Resonance Technologies

Base Molecular Resonance Technologies (BMRT) is a biotechnology company developing a non-invasive diagnostic and therapeutic platform based on proprietary resonance technology. The company's Base Molecular Resonance (BMR) system identifies unique frequency signatures of specific molecules, enabling the rapid detection of cancers, pathogens, and other biomarkers without the need for traditional chemical reagents. BMRT's technology aims to provide real-time, high-sensitivity results for a variety of clinical needs, including oncology and infectious disease management. The platform is designed to be portable and scalable, potentially transforming point-of-care diagnostics by identifying molecular structures through radio frequency spectroscopy. Currently, the company is focused on validating its detection capabilities across multiple high-impact indications such as sepsis and various solid tumors.